Impact



Implementation of HemoTypeSC Sickle Cell Disease Screening in Uganda

December 14, 2018

 
"If [HemoTypeSC] were to be widely implemented in newborn screening initiatives in sub-Saharan Africa and India, it could significantly reduce the mortality of the disease when combined with both treatment and counseling. This would potentially save millions of lives over several decades."
Read More

ASH Clinical News Interview - HemoTypeSC Late-Breaking Abstract

December 14, 2018

Erik Serrao discusses the data from a recently-completed field validation trial in southeastern Uganda.  In this collaboration with the Sickle Cell Association of Uganda, led by Ruth Nankanja, HemoTypeSC correctly identified the hemoglobin type of 1,000 out of 1,000 children screened.

Read More

"$2 Test Could Transform Sickle Cell Dx in Africa"

December 13, 2018

" 'HemoTypeSC is an accurate, inexpensive, and rapid tool that can enable sickle cell disease screening programs across rural areas of Africa and India, where it's not being screened for at all,' - late-breaking abstract press briefing at the American Society of Hematology meeting."

Read More

"New Sickle Cell Test Can Transform Screening"

December 13, 2018

  
 "A new test that costs less than $2, requires only a small drop of blood, and can be performed in about 10 minutes could dramatically change the dynamics of sickle cell diagnosis in Africa, say researchers who developed the product."
Read More

HemoTypeSC Presented in Late-Breaking Abstract

December 13, 2018

"A trial in Uganda showed a new test called HemoTypeSCTM was more than 99 percent accurate in detecting sickle cell disease in young children. The test requires only a small drop of blood and returns results in about 10 minutes, making it suitable for routine screening of newborns."
Read More

Lack of Funds Hinders Govt’s Policy on SCD

December 13, 2018

Dr. Alayo Sopekan, National Desk Officer, Ministry of Health, said: “Nigeria has the highest burden of Sickle Cell Disease (SCD) in the world ahead of Democratic Republic of Congo and India.”  He called for early diagnosis and treatment of the disease.

Read More

Nigerian Health Ministry Introduces POC Testing

January 30, 2018

Video: Nigerian officials reveal how the country loses over 150,000 newborns to sickle cell disease every year. OakTV presents a report on the accuracy of HemoTypeSC™, a 10 minute investigational test kit. 

Read More

Experts Advocate Newborn Screening for Sickle Cell

January 30, 2018

Video: Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.

Read More





HemoTypeSC™ has a CE Mark

The HemoTypeSC™ test has received the CE Mark, which is a certification that indicates conformity with health and safety standards set by the European Economic Area (EEA).  HemoTypeSC™ is thus commercially available as an IVD in the EEA, and the CE Mark will facilitate availability of the test to all African and Indian populations that need it most.